Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2023 Diversity, Equity, & Inclusion Report
    • 2023 Industry Snapshot
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 MA Life Sciences Workforce Analysis Report
    • Economic Development
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Bioversity at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Dong-A America Corp.

Life Sciences | Drug Development
Cambridge, MA Website

Overview

Dong-A ST Co Ltd (Dong-A ST) is a pharmaceutical company that manufactures and sells ethical drugs, medical devices, and diagnostic tests in S. Korea. The company offers ethical drugs including gonadopin injection, dulastin progression-free survival, mainta injection, monotaxel injection, motilitone tablet, suganon tablet, sugamet XR tablet, closerin capsule, growtropin II and leucostim. Dong-A ST also offers diagnostic solutions for identification of Malaria, dengue combo, anti-HBs, HBsAg, Hepatitis C, HIV 1/2, Syphilis and Ebola Ag diseases. The company is also engaged in the research to develop innovative drugs and aspires to become a world-class pharmaceutical company. It has recently acquired Neurobo in the fall of 2022 and started a US branch in Cambridge, MA in early 2023. Dong-A ST is headquartered in Seoul, South Korea and has achieved and maintained No.1 position in the Korean Pharmaceutical company since 1967.

 

 

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved